2021³â ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãß°èÇмú´ëȸ : 2021-11-21±³À°ÀÏÀÚ : 2021-11-21
±³À°Àå¼Ò : ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2021³â ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãß°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѼö¸éÈ£ÈíÇÐȸ
´ã´çÀÚ : ´ëÇѼö¸éÈ£ÈíÇÐȸ
¿¬¶ôó : 031-787-7420
À̸ÞÀÏ :
sleepbreathing@gmail.com ±³À°Á¾·ù : À̺ñÀÎÈÄ°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í *»çÀüµî·Ï½Ã Àü¹®ÀÇȸ¿ø : 1¸¸¿ø Àü¹®ÀÇ ºñȸ¿ø : 2¸¸¿ø Àü°øÀÇ ¹× ±âŸ : 1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 08:50~09:00 °³È¸»ç ¹× Àλ縻 ±¸¼ö±Ç (´ëÇѼö¸éÈ£ÈíÇÐȸÀå)
±âŸ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 09:00~10:10 Session I. Long-term effects and complications of surgery for obstructive sleep apnea (OSA) ÀÌÀç¼ (¼¿ï´ëº´¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 09:00~09:20 Effects of upper airway surgery on cardiovascular comorbidities and mortality Á¶¼º¿ì (ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 09:20~09:40 Long-term effects and complications of hypoglossal nerve stimulation ±è»ó¿í (°æ»ó´ëº´¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 09:40~10:00 Advantages of upper airway surgery superior to PAP therapy ±èÇöÁ÷ (¼¿ï´ëº´¿ø)
Åä·Ð 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 10:00~10:10 Q &A ()
ÈÞ½Ä 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 10:10~10:30 Coffee Break ()
±âŸ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 10:30~11:40 Session II. Home sleep apnea test (HSAT) ±è¼º¿Ï (°æÈñ´ëº´¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 10:30~10:50 Recent guidelines for clinical use of a HSAT ±èÈ¿¿ (»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 10:50~11:10 HSAT: accuracy vs cost-effectiveness ±è¿ë¹Î (Ãæ³²´ëº´¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 11:10~11:30 HSAT AASM scoring rules ÃÖÁöÈ£ (¼øõÇâ´ëºÎõº´¿ø)
Åä·Ð 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 11:30~11:40 Q &A ()
½Ä»ç 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 11:40~12:30 Lunch ()
±âŸ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 12:30~13:40 Session III. Pediatric OSA È«ÀÏÈñ (¼¿ï¼ö¸éÀÇ¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 12:30~12:50 Phenotypic variance in children with OSA Ç㼺Àç (°æºÏ´ëº´¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 12:50~13:10 Pediatric mild OSA: surgical therapy vs non-surgical therapy ¹è¿ì¿ë (µ¿¾Æ´ëº´¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 13:10~13:30 PAP therapy in pediatric OSA: critical effects and tips for good adherence Á¶ÇüÁÖ (½ÅÃ̼¼ºê¶õ½ºº´¿ø)
Åä·Ð 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 13:30~13:40 Q &A ()
ÈÞ½Ä 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 13:40~14:00 Coffee Break ()
±âŸ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 14:00~14:30 Session IV. Positive airway pressure (PAP): recall issue and referral system ±¸¼ö±Ç (ºÎ»ê¼º¸ðº´¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 14:00~14:15 PAP recall issue: reasons and harmful effects ±èµ¿Àº (°è¸í´ëµ¿»êÀÇ·á¿ø)
±³À°½Ã°£ 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 14:15~14:30 PAP recall issue: safety action and notice ¹ÚÂù¼ø (°¡Å縯´ë¼ººó¼¾Æ®º´¿ø)
Åä·Ð 11-21 ºÎ»ê´ëÇб³º´¿ø È£Èí±â¼¾ÅÍ(Rµ¿)13Ãþ ´ë°´ç 14:30~15:30 Panel discussion (Referral system for OSA patients with PAP therapy) ±èÁ¤ÈÆ,À̽ÂÈÆ,Á¶±Ô¼·,¿ÀÀç±¹,Á¤ÀçÈÆ,¹ÚÁ¾·ü(ºÐ´ç¼¿ï´ëº´¿ø,°í·Á´ë¾È»êº´¿ø,ºÎ»ê´ëº´¿ø,º¸¾Æ½ºÀ̺ñÀÎÈÄ°úÀÇ¿ø,ºÎ»ê¼ûÀ̺ñÀÎÈÄ°úÀÇ¿ø,ÀÌÁö¼ûÀ̺ñÀÎÈÄ°úÀÇ¿ø)